Tackling the emperor's wisdom: heat shock proteins to halt and reverse atrial fibrillation at its roots

Affiliations

B C du Pré et al. Neth Heart J. 2015 Jun.

. 2015 Jun;23(6):321-6.

doi: 10.1007/s12471-015-0698-1.

¹ Division of Heart and Lungs, Department of Medical Physiology, University Medical Center Utrecht, Utrecht, The Netherlands, A.A.B.vanVeen@umcutrecht.nl.

No abstract available

References

1. Lip GY, Beevers DG. ABC of atrial fibrillation. History, epidemiology, and importance of atrial fibrillation. BMJ. 1995;311:1361–3. doi: 10.1136/bmj.311.7016.1361. - DOI - PMC - PubMed
1. Lanters EA, Marion DM van, Steen H, Groot NM de, Brundel BJ. The future of atrial fibrillation therapy: intervention on heat shock proteins influencing electropathology is the next in line. Neth Heart J. 2015;23. doi:10.1007/s12471‐015‐0699‐0. - PMC - PubMed
1. Chang SL, Chen YC, Hsu CP. Heat shock protein inducer modifies arrhythmogenic substrate and inhibits atrial fibrillation in the failing heart. Int J Cardiol. 2013;168:4019–26. doi: 10.1016/j.ijcard.2013.06.072. - DOI - PubMed
1. Linde C, Gold MR, Abraham WT. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. Eur Heart J. 2013;34:2592–9. doi: 10.1093/eurheartj/eht160. - DOI - PubMed
1. Asimaki A, Kapoor S, Plovie E. Identification of a new modulator of the intercalated disc in a zebrafish model of arrhythmogenic cardiomyopathy. Sci Transl Med. 2014;6:240ra74. doi: 10.1126/scitranslmed.3008008. - DOI - PMC - PubMed